ANANDA Scientific Announces FDA approval of the IND for the Clinical Trial on the Treatment of Opioid Use Disorder (OUD)
Por um escritor misterioso
Descrição
ANANDA Scientific Inc., (a biotech pharma company) today announced approval by the U.S. Food and Drug Administration (FDA) of the Investigational New
The Evidence Supporting Treatment for Opioid Use Disorder (OUD)
Opiod Use Disorder - OUD Clinical Module
40th Annual Meeting of the Society for Medical Decision Making Montréal, Québec, Canada, October 13–17, 2018, 2019
Articles about Ananda Scientific
Ananda Scientific (@AnandaScience) / X
2016, Leaders in Pharmaceutical Business Intelligence (LPBI) Group
ANANDA Scientific
ANANDA Scientific announces FDA approval of the IND for the clinical trial on the treatment of Opioid Use Disorder (OUD) - ANTARA News
ANANDA Scientific Announces FDA approval of the IND for the Clinical Trial on the Treatment of Opioid Use Disorder (OUD)
